MedStone Pharma, headquartered in Weston, Florida, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. By building on the strengths of vertical integration in discovery research, process chemistry, formulation development and commercialization. MedStone Pharma possesses a portfolio that includes alternative dosage forms and many other differentiated products. MedStone Pharma is advancing a research and development (R&D) pipeline of several new products. We have an exciting innovative product pipeline coming in the next few years including several first-to-file and 505B2 opportunities, nasal sprays, dermatological, injectables, oncology products, and metered dose inhalers.